NasdaqGS - Nasdaq Real Time Price USD
Crinetics Pharmaceuticals, Inc. (CRNX)
31.24
+0.03
+(0.10%)
At close: May 16 at 4:00:02 PM EDT
31.24
0.00
(0.00%)
After hours: May 16 at 4:44:49 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 11 | 13 |
| Avg. Estimate | -1.1 | -1.17 | -4.41 | -4.6 |
| Low Estimate | -1.22 | -1.32 | -4.77 | -6.17 |
| High Estimate | -0.94 | -1.02 | -4.08 | -3.13 |
| Year Ago EPS | -0.94 | -0.96 | -3.69 | -4.41 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 13 | 14 |
| Avg. Estimate | 523.15k | 348.54k | 4.67M | 44.69M |
| Low Estimate | -- | -- | 1.7M | 26M |
| High Estimate | 5.14M | 2M | 8.78M | 108.78M |
| Year Ago Sales | 399k | -- | 1.04M | 4.67M |
| Sales Growth (year/est) | 31.12% | 0.00% | 349.58% | 856.70% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.86 | -0.91 | -0.89 | -0.95 |
| EPS Actual | -0.94 | -0.96 | -0.88 | -1.04 |
| Difference | -0.08 | -0.05 | 0.01 | -0.09 |
| Surprise % | -8.79% | -5.38% | 1.33% | -9.21% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.1 | -1.17 | -4.41 | -4.6 |
| 7 Days Ago | -1.04 | -1.13 | -4.17 | -4.57 |
| 30 Days Ago | -1.04 | -1.13 | -4.17 | -4.57 |
| 60 Days Ago | -1.02 | -1.11 | -4.13 | -4.49 |
| 90 Days Ago | -1 | -1.08 | -3.89 | -4.35 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | 3 | 1 | 4 | 2 |
| Down Last 30 Days | 3 | 3 | 4 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CRNX | -17.50% | -22.11% | -19.48% | -4.44% |
| S&P 500 | 13.21% | 2.76% | 7.83% | 13.78% |
Upgrades & Downgrades
| Initiated | Stifel: Buy | 3/25/2025 |
| Maintains | Citizens Capital Markets: Market Outperform to Market Outperform | 2/28/2025 |
| Initiated | Wolfe Research: Peer Perform | 2/4/2025 |
| Upgrade | Jefferies: Hold to Buy | 1/22/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/13/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 12/16/2024 |
Related Tickers
XENE Xenon Pharmaceuticals Inc.
30.29
+2.43%
IDYA IDEAYA Biosciences, Inc.
17.82
+2.95%
KRYS Krystal Biotech, Inc.
130.60
+0.21%
PCVX Vaxcyte, Inc.
31.85
+3.07%
MRUS Merus N.V.
41.56
+3.69%
AKRO Akero Therapeutics, Inc.
38.87
-2.73%
CYTK Cytokinetics, Incorporated
31.00
+3.89%
SRRK Scholar Rock Holding Corporation
30.55
-0.91%
PTGX Protagonist Therapeutics, Inc.
44.49
+0.18%
DNLI Denali Therapeutics Inc.
13.78
-2.68%